PATENT CLAIM ANALYSIS

Application Number: 15749485
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "357000"]

Abstract:
The present invention relates to a composition for use in treating a glioma or ameliorating the effects of a glioma, particularly glioblastoma, wherein said composition comprises a first active agent selected from the group consisting of a compound of formula (I), or a pharmaceutically acceptable salt thereof, (I) and a second active agent, which is temozolomide, or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.

Claim (Index 6):
The combination according to  claim 1 , wherein in formula (I), R5=H, O\u2014(C3-C6)alkyl, O(C2-C6)alkyl-OH, or O\u2014(C1-C3)alkyl-S\u2014(C1-C3)alkyl.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 86.0
- Lexical Diversity: 1.68085
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15316797', '14246558', '12878113', '13353713', '15467613']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7824305088011533
- 35 USC 102 Novelty (BERT): 0.5447849994938704
- Combined Prediction Score: 0.758665957870425
- Mean Citation Score: 278.55366200000003
- Max Citation Score: 398.48172
- Similarity Product: 288.5955240913438

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test